Dr. Joline Lim 林思静医生

Dr. Joline Lim is a medical oncologist at Curie Oncology and a visiting consultant at the National University Cancer Institute, Singapore (NCIS). She specializes in female cancers, particularly breast and gynecological oncology, with a strong focus on early phase clinical trials and translational research involving novel anti-cancer therapies and biomarkers. Prior to private practice, she served as a senior consultant at NCIS, clinician scientist at the Cancer Science Institute Singapore, and assistant professor at Yong Loo Lin School of Medicine, National University of Singapore. Dr. Lim graduated from the National University of Singapore in 2007 and completed her basic specialist training in internal medicine, obtaining Membership of the Royal College of Physicians (UK) in 2010. She later pursued research training at Harvard Medical School-affiliated institutions in Boston before completing advanced specialist training in medical oncology at NCIS. She was admitted as a Fellow of the Academy of Medicine, Singapore in 2015. Dr. Lim further advanced her expertise through fellowship training in early phase drug development at The Royal Marsden Hospital in the United Kingdom. She is actively involved in international clinical trials and translational research, particularly in targeted therapies and immunotherapy. Her work has been published in leading journals including the New England Journal of Medicine, Cancer Discovery, and Annals of Oncology. She also contributes to national research and oncology leadership through multiple committee roles. Bachelor of Medicine and Bachelor of Surgery (MBBS) — National University of Singapore, 2007 MRCP (UK) — Member of the Royal College of Physicians, United Kingdom FAMS (Medical Oncology) — Fellow of the Academy of Medicine, Singapore Fellowship in Early Phase Drug Development — The Royal Marsden Hospital, United Kingdom